[ALNY] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
31-Oct-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -560.61%
YoY- -175.51%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 500,919 750,530 264,306 187,633 125,853 70,061 2,069 149.44%
PBT -108,663 150,741 -405,943 -204,236 -252,452 -208,929 -244,837 -12.65%
Tax 2,907 2,988 -23 278 839 -394 445 36.68%
NP -111,570 147,753 -405,920 -204,514 -253,291 -208,535 -245,282 -12.29%
Tax Rate - -1.98% - - - - - -
Total Cost 612,489 602,777 670,226 392,147 379,144 278,596 247,351 16.29%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -22.27 19.69 -153.58 -109.00 -201.26 -297.65 -11,855.10 -64.83%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.87 1.18 -3.32 -1.72 -2.18 -1.92 -2.43 -15.72%
EPS Diluted -0.87 1.15 -3.32 -1.72 -2.18 -1.92 -2.43 -15.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.